Key result
PCI for cardiogenic shock STEMI carries ~54% in-hospital mortality linked to ischemic time and CPR.
Why the study?
Studying outcomes in patients with cardiogenic shock complicating STEMI undergoing PCI may identify unmet needs and inform future recommendations to improve survival.
What are the predictors of short-term in-hospital mortality in patients undergoing PCI for cardiogenic shock complicating STEMI?
Cohort (n=114)
No
What are the predictors of short-term in-hospital mortality in patients undergoing PCI for cardiogenic shock complicating STEMI?
In-hospital mortality for CS-STEMI patients undergoing PCI remains high at 53.5%, driven by factors like ischemic time, LVEF, need for CPR, and post-PCI TIMI flow, with no significant improvement over a 16-year period.
Answers are grounded in this paper and cite their sources.
High mortality in CS-STEMI PCI highlights need to minimize ischemic time and optimize post-PCI flow; leaves open whether predictors are modifiable targets.
BACKGROUND: Studying the outcomes in patients presenting with cardiogenic shock with ST-segment elevation myocardial infarction (CS-STEMI) and undergoing primary or rescue percutaneous coronary intervention (PCI) may give an insight to the unmet needs in STEMI-care in our region and may help in future recommendations in improving survival. MATERIALS AND METHODOLGY: During the period from January 2001- June 2017, there were 114 patients included in the study. The demographic, clinical and angiographic characteristics were compared between the survivors and non-survivors. All these variables were also compared between two-time frames (Phase 1- January 2001 to June 2007; Phase 2- July 2007 to June 2017). RESULTS: Among patients undergoing PCI for STEMI, 7.5% were in cardiogenic shock. In-hospital mortality for the patients included in the study was 53.5%. Total ischemic time (OR=0.99, 0.99-1; p=0.02), left ventricular ejection fraction (LVEF) (OR=0.90, 0.82-0.98; p=0.02), need for cardio-pulmonary resuscitation (OR=0.12, 0.24-0.66; p=0.01), and post PCI TIMI flows (OR=0.08, 0.02-0.29; p<0.001) were the significant determinants of in-hospital mortality in the regression analysis. There was no significant change in mortality between the two phases of the study, though there was a reduction in total ischemic and door-to-balloon times, transfer admissions, use of thrombolytics, glycoprotein IIb/IIIa inhibitors, intra-aortic balloon pump, and mechanical ventilation in phase 2. CONCLUSION: Patients presenting in CS-STEMI and undergoing PCI continue to experience high mortality rates, despite improvements in total ischemic times. Further improvement in the systems-of-care are required to bring about reduction in mortality in this high-risk subset.
No takes yet. Share an insight, caveat, or question.
Raja et al. (2018) conducted a cohort in Cardiogenic shock complicating ST-segment elevation myocardial infarction (CS-STEMI) (n=114). Clinical and angiographic characteristics (total ischemic time, LVEF, CPR, post-PCI TIMI flow) was evaluated on In-hospital mortality. In patients undergoing PCI for CS-STEMI, in-hospital mortality was 53.5%, with total ischemic time, LVEF, need for CPR, and post-PCI TIMI flows identified as significant determinants of mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: